Related Experiment Videos
Risk factors of stroke after percutaneous transluminal coronary angioplasty
1Neurology Department and Hemodynamic Unit, Hospital Clinico San Carlos, Madrid, Spain.
Insights
Stroke after percutaneous transluminal coronary angioplasty (PTCA) is rare but serious. Key risk factors for stroke post-PTCA include thrombolytic therapy, hypercholesterolemia, and prior PTCA procedures.
Area of Science:
- Cardiology
- Neurology
- Vascular Surgery
Background:
- Percutaneous transluminal coronary angioplasty (PTCA) is a common procedure for coronary artery disease.
- Stroke is a potential complication following cardiovascular interventions.
- Identifying risk factors for stroke after PTCA is crucial for patient management.
Purpose of the Study:
- To investigate the incidence and risk factors associated with stroke after PTCA.
- To analyze the clinical characteristics and outcomes of patients experiencing stroke post-PTCA.
Main Methods:
- Retrospective evaluation of 4088 consecutive patients undergoing PTCA between 1988 and 1995.
- Comparison of stroke patients with a control group to identify significant risk factors.
- Analysis of stroke types (ischemic, hemorrhagic) and transient ischemic attacks (TIA).
Main Results:
- Seven patients (0.17%) experienced stroke post-PTCA; six cerebral and one spinal.
- Statistically significant risk factors identified: intracoronary thrombolytic therapy (P < 0.01), hypercholesterolemia (P < 0.001), and prior PTCA (P < 0.05).
- Hemorrhagic strokes occurred exclusively after thrombolytic therapy.
Conclusions:
- Stroke following PTCA, though infrequent, is a serious complication.
- Pre-procedural identification of risk factors like hypercholesterolemia and prior PTCA can help identify at-risk patients.
- Factors predisposing to hemorrhagic versus ischemic strokes and TIA may differ.
Abstract:
Objective: to determine possible risk factors of a stroke after percutaneous transluminal coronary angioplasty (PTCA). Design: this is a retrospective evaluation of a consecutive group of 4088 patients undergoing PTCA between 1988 and 1995. We have studied the incidence, clinical characteristics, risk factors, and outcome. Results: seven patients, six males and one female (0.17%) developed a stroke after this procedure. In comparison with the control group, the stroke group did not differ regarding age or gender. The existence of a stroke (six located in the brain, and one in the spinal cord), represented 1.24% of all complications (P < 0.001), and 5% of all deaths (P < 0.01) of PTCA. Three patients developed TIA, two patients developed hemorrhagic strokes (in which they received previous thrombolytic therapy), and the other two patients suffered from an ischemic stroke. The statistically significant risk factors of a stroke after PTCA included: intracoronary thrombolytic therapy (P < 0.01), hypercholesterolemia (P < 0.001) and a prior PTCA (P < 0.05). Conclusions: although these procedural complications are infrequent, they are usually serious and important risk factors which could be identified prior to the procedure. These risk factors would allow identification of patients who are prone to a stroke after PTCA. Intracranial hemorrhage occurred only after thrombolytic therapy, and the factors related to hemorrhagic strokes were probably different from those predisposed to ischemic strokes and TIA. Copyright 1998 Lippincott Williams & Wilkins